Researcher
Marc Peeters
- Research Expertise (University of Antwerp):My expertise is in the field of oncology or cancer research. It is mainly focused on clinical translational research. This domain is very broad and ranges from bio-research to clinical studies
- Keywords (University of Antwerp):ONCOLOGY, Medicine
- Disciplines (Ghent University):Endocrinology and metabolic diseases, Paediatrics and neonatology, Nursing
- Disciplines (University of Antwerp):Cancer therapy, Cancer biology, Cancer diagnosis, Cancer epidemiology, Cancer prevention
- Research techniques (University of Antwerp):Making protocols for studies. (Statistical) analysis of results
- Users of research expertise (University of Antwerp):Other researchers in the field. Students Pharma and Biotech companies
- See also: Marc Peeters (Ghent University)
Affiliations
- Center for Oncological Research (CORE) (Research group)
Member
From1 Jan 2019 → Today - Department of Internal Medicine and Pediatrics (Department)
Member
From1 Oct 2018 → Today - Molecular Imaging, Pathology, Radiotherapy & Oncology (MIPRO) (Research group)
Responsible
From1 Oct 2009 → 31 Dec 2018 - Department of Internal medicine (Department)
Member
From1 Oct 2000 → 30 Sep 2018
Projects
1 - 10 of 67
- Dawn of a new era in drug discovery: the symphony of AI-guided small molecule design with 3D patient-derived tumor organoids.From1 Jan 2024 → TodayFunding: IOF - technology concept exploration
- Trapped ion mobility quadrupole time of flight mass spectrometer hyphenated to automated high throughput liquid chromatography.From30 Jun 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Neuroendocrine neoplasms from bench to bedside: unravelling personalised strategies through the integration of clinical data and patientderived organoids.From1 Mar 2023 → 29 Feb 2024Funding: Nonprofit institution or equivalents
- Detection and quantification of a panel of clinically relevant DNA biomarker sequences containing KRAS mutations in tissue and liquid biopsies via a novel photoelectrochemical technology.From1 Jan 2023 → TodayFunding: FWO Humanitarian research project Stand up against Cancer
- Multiplexed photoelectrochemical detection technology for molecular cancer biomarkers (MultiSens).From1 Jan 2023 → 31 Dec 2023Funding: IOF - technology validation in lab
- A new photoelectrochemical singlet oxygen-based detection platform for a panel of cancer biomarkers in tissue and liquid biopsies (SOCAN).From1 Jan 2023 → TodayFunding: BOF - iBOF, University - Project driven research
- Improving diagnostic accuracy and follow-up of neuroendocrine neoplasms through detection of (epi)genetic biomarkers in liquid biopsies using novel technological platforms.From1 Nov 2022 → TodayFunding: FWO Strategic Basic Research Grant
- Investigation to reveal the immune reaction upon COVID vaccination in the Belgian cancer population: COVID protection and vaccine safety (REAL-V).From1 Oct 2022 → TodayFunding: Nonprofit institution or equivalents
- Towards informed decisions in colorectal cancer screening (ORIENT).From15 Aug 2022 → TodayFunding: Nonprofit institution or equivalents
- Center for Proteomics (CfP).From1 Jan 2022 → TodayFunding: BOF - research organisations
Publications
351 - 360 of 385
- Role of cell cycle perturbations in the combination therapy of chemotherapeutic agents and radiation(2010)
Authors: Bea Pauwels, An Wouters, Marc Peeters, Jan Vermorken
Pages: 1485 - 1496 - **KRAS** mutation detection and prognostic potential in sporadic colorectal cancer using high-resolution melting analysis(2010)
Authors: Carolien Boeckx, Marc Baay, Joost Weyler, Wim Wuyts, Marc Peeters, Filip Lardon, Jan Vermorken
Pages: 1627 - 1636 - The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model(2010)
Authors: I. Debergh, N. Van Damme, P. Pattyn, Marc Peeters, W.P. Ceelen
Pages: 837 - 843 - Expression of hexokinases and glucose transporters in treated and untreated oesophageal adenocarcinoma(2009)
Authors: Philippe Fonteyne, Veerle Casneuf, Patrick Pauwels, Nancy Van Damme, Marc Peeters, Rudi Dierckx, Christophe Van de Wiele
Pages: 971 - 977 - Human equilibrative nucleoside transporter 1 and human concentrative nucleoside transporter 3 predict survival after adjuvant gemcitabine therapy in resected pancreatic adenocarcinoma(2009)
Authors: Raphaël Maréchal, John R. Mackey, Raymond Lai, Pieter Demetter, Marc Peeters, Marc Polus, Carol E. Cass, James Young, Isabelle Salmon, Jacques Devière, et al.
Pages: 2913 - 2919 - The role of surgery and transplantation in neuroendocrine tumours(2009)
Authors: Geert Roeyen, I. Borbath, Marc Peeters, Dirk Ysebaert, et al.
Pages: 39 - 43 - Carcinoid heart disease: a hidden complication of neuroendocrine tumours(2009)
Authors: I. Dero, M. de Pauw, I. Borbath, T. Delaunoit, P. Demetter, G. Demolin, A. Hendlisz, P. Pattyn, S. Pauwels, Geert Roeyen, et al.
Pages: 34 - 38 - Feasibility of radiotherapy with concomitant gemcitabine and oxaliplatin in locally advanced pancreatic cancer and distal cholangiocarcinoma(2009)
Authors: S. Laurent, E. Monsaert, T. Boterberg, A. Demols, I. Borbath, M. Polus, A. Hendlisz, B. de Hemptinne, C. Mahin, Scalliet, et al.
Pages: 1369 - 1374 - Locoregional and radioisotopic targeted treatment of neuroendocrine tumours(2009)
Authors: A. Hendlisz, P. Flamen, M. van den Eynde, Marc Peeters, Geert Roeyen, et al.
Pages: 44 - 48 - Amphiregulin and epiregulin mRNA expression in primary tumors predicts outcome in metastatic colorectal cancer treated with cetuximab(2009)
Authors: Bert Jacobs, Wendy De Roock, Hubert Piessevaux, Marc Peeters, et al.
Pages: 5068 - 5074
Patents
1 - 6 of 6
- Combination immunotherapy of il-15 and cd40 agonist in cancer treatment (Inventor)
- Combination immunotherapy of IL-15 and CD40 agonist in cancer treatment (Inventor)
- Methylation detection assay (Inventor)
- Methylation status of gasdermin E gene as cancer biomarker (Inventor)
- Combination immunotherapy of IL-15 and CD40 agonist in cancer treatment (Inventor)
- Methylation status of gasdermin e gene as cancer biomarker (Inventor)